Opus Investment Management Inc. maintained its position in Clorox Company (The) (NYSE:CLX) during the second quarter, Holdings Channel reports. The institutional investor owned 5,000 shares of the company’s stock at the end of the second quarter. Opus Investment Management Inc.’s holdings in Clorox Company (The) were worth $666,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. American Beacon Advisors Inc. bought a new stake in shares of Clorox Company (The) during the first quarter worth $104,000. Quadrant Capital Group LLC increased its stake in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock worth $106,000 after buying an additional 158 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in shares of Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after buying an additional 29 shares in the last quarter. Valley National Advisers Inc. increased its stake in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares in the last quarter. Finally, Blue Chip Partners Inc. increased its stake in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares in the last quarter. Institutional investors own 70.29% of the company’s stock.

Clorox Company (NYSE CLX) opened at 134.31 on Friday. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The stock has a market capitalization of $17.34 billion, a P/E ratio of 25.18 and a beta of 0.40. The firm’s 50 day moving average is $133.58 and its 200 day moving average is $133.56.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company’s quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the company earned $1.30 earnings per share. On average, equities research analysts anticipate that Clorox Company will post $5.67 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Opus Investment Management Inc. Continues to Hold Stake in Clorox Company (The) (CLX)” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.watchlistnews.com/opus-investment-management-inc-continues-to-hold-stake-in-clorox-company-the-clx/1476840.html.

A number of equities research analysts recently weighed in on CLX shares. Jefferies Group LLC started coverage on shares of Clorox Company (The) in a research note on Tuesday, April 18th. They issued a “hold” rating and a $138.00 target price on the stock. Vetr downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 target price on the stock. in a research note on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 target price on shares of Clorox Company (The) and gave the company a “hold” rating in a research note on Monday, April 24th. BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Finally, UBS AG reaffirmed a “sell” rating and issued a $121.00 target price (up from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. Clorox Company (The) currently has an average rating of “Hold” and a consensus price target of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.